Biotech | April 18, 2022
Albumedix and Valneva expand collaboration to include newly approved inactivated Covid-19 vaccine
This marks an expansion of the companies' existing collaboration and further validates the use of Albumedix Recombumin rHA products in the manufacturing process and final formulation of critical vaccines
